Ratios
Cell Therapeutics, Inc. (CTIC.O) (Consolidated Issue listed on NASDAQ Capital Market)
Valuation Ratios |
Dividends |
Growth Rates |
Financial Strength |
Profitability Ratios |
Management Effectiveness |
Efficiency
Valuation Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 12.80 | 4.81 | 123.07 |
| P/E High - Last 5 Yrs. | NA | 11.60 | 2.05 | 24.60 |
| P/E Low - Last 5 Yrs. | NA | 4.85 | 0.64 | 5.65 |
| Beta | 7.11 | 0.59 | 0.65 | 1.38 |
| Price to Sales (TTM) | 246.69 | 29.90 | 1.34 | 2.02 |
| Price to Book (MRQ) | -- | 3.74 | 2.01 | 2.50 |
| Price to Tangible Book (MRQ) | -- | 18.12 | 3.58 | 6.24 |
| Price to Cash Flow (TTM) | -- | 9.22 | 2.87 | 15.46 |
| Price to Free Cash Flow (TTM) | -- | 41.26 | 34.48 | 21.45 |
| % Owned Institutions | -- | -- | -- | -- |
Dividends
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Dividend Yield | NA | 0.02 | 0.24 | 1.51 |
| Dividend Yield - 5 Year Avg. | 0.00 | 0.04 | 1.59 | 2.76 |
| Dividend 5 Year Growth Rate | -- | 0.38 | 14.73 | 9.49 |
| Payout Ratio(TTM) | -- | 0.65 | 7.72 | 88.82 |
Growth Rates
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -99.23 | 64.32 | 5.57 | -4.00 |
| Sales (TTM) vs TTM 1 Yr. Ago | -70.86 | 10.11 | 2.03 | -5.07 |
| Sales - 5 Yr. Growth Rate | -14.32 | 22.31 | 7.91 | 15.67 |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 96.73 | 54.50 | 100.92 | 75.46 |
| EPS (TTM) vs TTM 1 Yr. Ago | 96.92 | -- | -- | -- |
| EPS - 5 Yr. Growth Rate | -- | 10.51 | 5.14 | 1.15 |
| Capital Spending - 5 Yr. Growth Rate | -10.55 | 3.97 | 6.76 | 19.60 |
Financial Strength
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Quick Ratio (MRQ) | 0.82 | 6.28 | 2.56 | 0.84 |
| Current Ratio (MRQ) | 0.82 | 6.70 | 3.06 | 0.99 |
| LT Debt to Equity (MRQ) | -- | 24.27 | 26.33 | 130.42 |
| Total Debt to Equity (MRQ) | -- | 28.92 | 33.97 | 201.14 |
| Interest Coverage (TTM) | -2.28 | 5.25 | 9.93 | 26.27 |
Profitability Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Gross Margin (TTM) | 65.68 | 41.02 | 15.67 | 26.96 |
| Gross Margin - 5 Yr. Avg. | 91.43 | 52.91 | 56.58 | 26.64 |
| EBITD Margin (TTM) | -2,636.43 | -- | -- | -- |
| EBITD - 5 Yr. Avg | -918.79 | -154.03 | 16.81 | 15.38 |
| Operating Margin (TTM) | -2,874.73 | -478.12 | -5.31 | -- |
| Operating Margin - 5 Yr. Avg. | -983.45 | -181.31 | 12.18 | 20.09 |
| Pre-Tax Margin (TTM) | -4,083.86 | -466.90 | -5.02 | 7.74 |
| Pre-Tax Margin - 5 Yr. Avg. | -1,411.19 | -172.22 | 14.06 | 19.80 |
| Net Profit Margin (TTM) | -4,083.86 | -469.43 | -6.06 | 6.26 |
| Net Profit Margin - 5 Yr. Avg. | -1,411.19 | -175.28 | 7.86 | 14.04 |
| Effective Tax Rate (TTM) | -- | 9.03 | 4.96 | -7.68 |
| Effecitve Tax Rate - 5 Yr. Avg. | -- | 16.36 | 33.89 | 28.10 |
Management Effectiveness
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Return on Assets (TTM) | -117.66 | 2.35 | 2.27 | 3.65 |
| Return on Assets - 5 Yr. Avg. | -130.28 | -3.12 | 6.92 | 5.27 |
| Return on Investment (TTM) | -310.50 | 2.35 | 2.89 | 5.00 |
| Return on Investment - 5 Yr. Avg. | -188.04 | -3.40 | 8.94 | 6.77 |
| Return on Equity (TTM) | -- | 3.59 | 4.25 | 8.73 |
| Return on Equity - 5 Yr. Avg. | -- | -4.15 | 10.67 | 15.25 |
Efficiency
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Revenue/Employee (TTM) | 13,726 | 595,996 | 1,435,239 | 471,353 |
| Net Income/Employee (TTM) | -560,563 | -21,327 | 224,801 | 30,983 |
| Receivable Turnover (TTM) | 3.28 | 14.34 | 1.41 | 6.87 |
| Inventory Turnover (TTM) | -- | 1.77 | 0.79 | 5.32 |
| Asset Turnover (TTM) | 0.03 | 0.29 | 0.15 | 0.45 |
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes.
For a complete list of exchanges and delays, please click here.
